{
    "title": "AbbVie takes $2.1 bln charge on cancer drug ahead of US price negotiation",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12680625/AbbVie-takes-2-1-bln-charge-cancer-drug-ahead-US-price-negotiation.html",
    "date": "2023-10-27",
    "keywords": [
        "price",
        "drug",
        "humira",
        "analyst",
        "profit",
        "leo",
        "santhosh",
        "government",
        "imbruvica",
        "friday",
        "revenue",
        "effect",
        "insurance",
        "year",
        "medicare",
        "quarter",
        "view",
        "competition",
        "share",
        "bigselling",
        "cancer",
        "charge",
        "drop",
        "pill",
        "august",
        "firstever",
        "goal",
        "abbvie",
        "placeholder",
        "decrease",
        "future",
        "cash",
        "program",
        "age",
        "street",
        "morningstar",
        "damien",
        "conover",
        "hit",
        "update",
        "impairment",
        "forecast",
        "face",
        "afternoon",
        "trading",
        "weakness",
        "stock",
        "selloff",
        "business",
        "christopher",
        "raymond",
        "thirdquarter",
        "dozen",
        "market",
        "amgen",
        "boehringer",
        "ingelheim",
        "coverage",
        "july",
        "erosion",
        "companys",
        "immunology",
        "skyrizi",
        "rinvoq",
        "range",
        "month",
        "bengaluru",
        "editing",
        "maju",
        "samuel",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}